News

Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs

Diabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.

Proteins common to Alzheimer disease play a significant role in glaucoma

Quantitative and qualitative improvement in IOL design

Researchers investigated patients' ability to drive and work following eye injury

A case study emphasises the shifting paradigm in clinical best practices

Good news for patients: use of anti-complement therapies have caused the growth rate of GA lesions to decrease

Research indicates smoking increases risk of AMD, cataracts and glaucoma

Kiora also stated a Phase 2 trial of KIO-104 is expected to begin later this year

Investigators emphasised that the data does not indicate a causal relationship between the eye disorder and systemic diseases

Clara Chan, MD, shares surgical pearls for neurotrophic keratopathy and explores new pathways through neurotisation

The approval marks the first new steroid on the US ophthalmic market in more than 15 years

A longitudinal, AI-based approach to fluid quantification

Mentorship, leadership and addressing bias are key areas for improvement

The algorithms could provide major accessibility improvements and cost savings to underdeveloped regions

Penetrating keratoplasty remains a popular choice for certain patients

The kidney and eye are structurally similar and the diseases of the organs may present via common pathways

The authors suggested genetic mutation may relax the body’s defences and allow harmful bacteria to reach the eye

The Retinopathy of Prematurity (ROP) Education and Support Programme is part of ROP Awareness Week, recognised from 26 February to 3 March

Innovative therapies scale up to meet needs of a growing patient population

Patient age is significant in the long-term effect of orthokeratology lenses

Optical coherence tomography angiography could also identify patients at risk of disease progression

The company made its CE Mark announcement during the ESCRS Winter Meeting

Physicians explore how other specialties adopt and integrate remote monitoring

The Phase 2/3 VISTA trial for AGTC-501 in XLRP is expected to begin in in the first half of 2024

The company, headquarted in New York and London, named OK-101 as the first IND clearance granted by the FDA for a drug to begin clinical studies specifically to treat NCP

The technology has potential for applications in contact lenses and intraocular implants

According to the company, the patent further protects Iridex’s intellectual property encompassing laser systems in ophthalmology and related fields

An investment from the Sir Jules Thorn Charitable Trust will support a state-of-the-art building, opening in 2027